Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Type-II adeno-associated virus carrying neuritin genes and application thereof in restoring optic nerve injuries

A gene and virus technology, applied in the application field of type Ⅱ adeno-associated virus, repairing optic nerve damage, to achieve the effect of enhancing internal regeneration ability, promoting optic nerve regeneration, improving survival and regeneration

Inactive Publication Date: 2013-07-31
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
View PDF0 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] At present, there is no literature report that the Neuritin gene is related to the repair of optic nerve damage, and there is no literature report on the construction of a type Ⅱ adeno-associated virus vector carrying the Neuritin gene to treat optic nerve damage

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Type-II adeno-associated virus carrying neuritin genes and application thereof in restoring optic nerve injuries
  • Type-II adeno-associated virus carrying neuritin genes and application thereof in restoring optic nerve injuries
  • Type-II adeno-associated virus carrying neuritin genes and application thereof in restoring optic nerve injuries

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] 1. Construction of Neuritin gene type Ⅱ adeno-associated virus expression vector

[0045] (1) Type II adeno-associated virus expression vector and enzyme digestion of target gene

[0046] The pAOV-CAG-eGFP vector (purchased from Addgene) was used to carry out enzyme digestion with Not I and Mlu I, and the digested vector was prepared for use in vector construction. Using the cDNA clone of the CDS region of the NRN1 gene as a template, the NRN1 gene fragment was amplified by PCR, and the product was digested with Not I and Mlu I, and the vector and target gene DNA were recovered after identification by agarose gel electrophoresis.

[0047] (2) Ligation reaction

[0048] The digested type II adeno-associated virus vector and the PCR product of the NRN1 gene were ligated according to the reaction system in Table 1.

[0049] Table 1: Ligation reaction system

[0050]

[0051] After the above reagents were mixed, they were ligated at 4°C for 12 hours to prepare the cloni...

Embodiment 2

[0066] 1. Culture and induction of RGC5 differentiation

[0067] RGC5 is the retinal ganglion cell line of a one-day-old rat (see [20] Krishnamoorthy RR, Agarwal P, Prasanna G, et al. Characterization of a transformed rat retina ganglion cell line. Brain Res Mol Brain Res. 2001; 86(1-2):1-12.), immature, first induced by staurosporine to differentiate into mature neuron-like cells ( figure 1 ). RGC5 before induction was cultured in high-glucose DMEM medium and 5% serum in a place containing 5% CO 2 , in an incubator at 37°C, and the cells were passaged once a day. When used, 326nM staurosporine was used to induce for 24 hours.

[0068] 2. Overexpression of Neuritin gene and establishment of RGC5 injury model

[0069] When RGC5 was cultured to 80% confluence, add the appropriate amount of type II adeno-associated virus and a certain amount of polybrene at a pre-measured concentration, and replace it with normal medium after 24 hours, observe the expression of RFP with a flu...

Embodiment 3

[0081] 1. In vivo transfection of retinal ganglion cells with type Ⅱ adeno-associated virus and overexpression of Neuritin

[0082] Inject neuritin type Ⅱ adeno-associated virus into the vitreous body, and perfuse the mice with 4% paraformaldehyde one week later, take retinal slices, and use immunohistochemical β-Ⅲ-tubulin staining or cholera toxin B subunit (CTB) injection to co-localize the retina Ganglion cells to observe the transfection effect, the transfection efficiency is about 90% or more (such as Figure 5 shown).

[0083] Western blot and immunohistochemical methods were used to observe the overexpression and localization of Neuritin protein after Neuritin type Ⅱ adeno-associated virus transfection.

[0084] 2. Establishment of Optic Nerve Injury Model

[0085] The present invention adopts the optic nerve crush model, and uses Yasargil cerebral aneurysm clip to clip the optic nerve of adult male rats about 1 mm behind the eyeball and wound for 9 seconds. For speci...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of gene engineering and nerve injuries. Optic nerve injuries are common eye diseases and external injuries, and cause the optic nerve atrophia and blindness of patients when the optic nerve injuries are severe, and at present, the clinic actual curative effect is unsatisfactory. The invention provides a type-II adeno-associated virus carrying neuritin genes and a building method thereof, the invention also further provides the application of the type-II adeno-associated virus carrying neuritin genes in preparing medicaments for restoring optic nerve injuries.

Description

technical field [0001] The invention belongs to the technical field of genetic engineering and nerve injury, and specifically relates to a type II adeno-associated virus carrying Neuritin gene and its application in repairing optic nerve injury. Background technique [0002] Optic nerve injury is a common link of many eye diseases and traumas, such as glaucoma, optic nerve ischemia, blunt trauma, optic canal fracture, etc., leading to visual function damage, and in severe cases, it will cause optic nerve atrophy and blindness in patients. Although a lot of research work has been carried out on the treatment of optic nerve injury, its clinical efficacy is unsatisfactory, and it is difficult to restore vision to patients according to the current medical technology level. The low intrinsic regenerative ability of retinal ganglion cells (RGCs) is the key factor for optic nerve atrophy and blindness caused by regeneration failure after optic nerve injury. How to carry out effecti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/864C12N15/66A61K48/00A61P25/02A61P27/02
Inventor 许家军曹文珞刘芳蔺海燕
Owner SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com